Company / Revenue per Share
ENvue Medical, Inc. Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$67.50
FY2025
5-year range
$0.03 / $67.50
FY2021-FY2025
Trend
+450.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share changed +450% YoY in FY2025, a notable deviation from the 9-year average annual change of +751%.
Based on SEC 10-K filings.
67.50 in FY2025 with a 5-year CAGR of +251.3%.
Improved from $0.46 to $67.50 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +282.0%
- 5-Year CAGR
- +251.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, revenue per share increased 450.1% year-over-year.
- Lowest revenue per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.19 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $67.50 | +450.1% |
| FY2024 | $12.27 | +2578.3% |
| FY2023 | $0.46 | -62.2% |
| FY2022 | $1.21 | +3757.9% |
| FY2021 | $0.03 | -75.1% |
| FY2020 | $0.13 | +50.7% |
| FY2019 | $0.08 | +37.8% |
| FY2018 | $0.06 | -30.2% |
| FY2017 | $0.09 | +54.5% |
| FY2016 | $0.06 | -95.5% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026